Skip to content

Hormone measurements after salt loading

Establishing assay-specific reference ranges for the oral salt loading test - RAASREF2

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57731
Enrollment
120
Registered
2025-02-20
Start date
2025-10-13
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary aldosteronism primary aldosteronism

Interventions

response of renin and aldosterone to salt loading

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: healthy male and female subjectsnormal blood pressure, i.e. office systolic blood pressure < 140 and diastolic blood pressure < 90 mmHg

Exclusion criteria

Exclusion criteria: hypertension (systolic blood pressure > 140 mmHg and/or diastolic blood pressure > 90 mmHg past medical history of heart failure, myocardial infarction, stroke, TIA, peripheral arterial disease or adrenal gland disorderelevated liver enzymes (ALAT/ASAT/gammaGT/AF > 1.5 times URL)renal insufficiency (eGFR < 60 mL/min/1.73m2 ) diabetes mellitus (any type) pregnancyuse of one of the following drugs: ACE- inhibitors,angiotensin receptor blockers, renin blockers, calcium channel blockers, diuretics, betablockers, alphablockers, centrally acting antihypertensives (like clonidine, moxonidine, methyldopa), nonsteroidal anti-inflammatory drugs, potassium supplements, glycyrrhizin containing products 

Design outcomes

Primary

MeasureTime frame
95% confidence intervals of renine and aldosterone before and after a 3-day oral salt loading test.

Secondary

MeasureTime frame
conversion factors between the assays for determination of renin and aldosterone

Countries

Netherlands

Contacts

Public ContactMN Kerstens

Universitair Medisch Centrum Groningen

m.n.kerstens@umcg.nl+31-50-3616161

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 25, 2026